EMA Committee Recommends Broader Use of Merck’s Preventive RSV Treatment
The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending an expanded indication for Merck’s preventive RSV treatment.
By Connor HartMerck's preventive treatment for respiratory syncytial virus cleared a regulatory hurdle, with a European Medicines Agency committee recommending an expanded indication.The Committee for Medicinal Products for Human Use adopted a positive opinion recommending the use of the treatment…